Clolar Approval History
- FDA approved: Yes (First approved December 28th, 2004)
- Brand name: Clolar
- Generic name: clofarabine
- Company: Genzyme Corp.
- Treatment for: Acute Lymphoblastic Leukemia
Clolar (clofarabine) is a purine nucleoside anti-metabolite indicated for the treatment of children with refractory or relapsed acute lymphoblastic leukemia (ALL).
FDA Approval History for Clolar
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.